UNIVERSAL TECHNICAL INSTITUTE INC (UTI)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $3.9M
- Jun 29 · No plan
- Form 4 sales
- 147
- On record
- Form 144 notices
- 32
- Proposed sales
- Sold, last 30 days
- None
- No Form 4 sale
- Sold, last 90 days
- None
- No Form 4 sale
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- Jun 29, 2026No plan
Grant Jerome Alan, Chief Executive Officer, sold 22% of their holdings
$3.9M94,500 shares at $41.40
- Jun 29, 2026Notice
Grant Jerome Alan, Chief Executive Officer, filed a notice to sell 94,500 shares
$3.9M94,500 shares
- Jun 22, 2026No plan
Prehn Kevin, Concorde Division President, sold 14.4% of their holdings
$182k4,545 shares at $40.00
- Jun 22, 2026Notice
Prehn Kevin, Concorde Division President, filed a notice to sell 4,545 shares
$182k4,545 shares
- Jun 8, 2026Unusual
Coliseum Capital Partners, L.P., Director, sold 75.5% of their holdings
$124M3M shares at $41.40
- Jun 8, 2026Notice
Coliseum Capital Management, LLC, Director, filed a notice to sell 4M shares
$173M4M shares
- Jun 5, 2026No plan
Kline Christine, Senior Vice President and CAO, sold 7.5% of their holdings
$155k3,500 shares at $44.42
- Jun 5, 2026Notice
Kline Christine, Senior Vice President and CAO, filed a notice to sell 3,500 shares
$155k3,500 shares
- May 11, 2026No plan
Srere Linda J, Director, sold 10.5% of their holdings
$549k15,000 shares at $36.59
- May 11, 2026Notice
Srere Linda J, Director, filed a notice to sell 15,000 shares
$536k15,000 shares
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | Sep 30, 2026 | UTI | Devincenzi Robert Thomas | Director | Bought | 1,000 | $19.68 | $20k | 153,330 | SEC |
| Sep 21, 2026 | Sep 23, 2026 | UTI | Devincenzi Robert Thomas | Director | Bought | 1,000 | $19.83 | $20k | 152,330 | SEC |
| Aug 27, 2026 | Aug 31, 2026 | UTI | Devincenzi Robert Thomas | Director | Bought | 1,000 | $21.80 | $22k | 151,330 | SEC |
| Aug 25, 2026 | Aug 27, 2026 | UTI | Devincenzi Robert Thomas | Director | Bought | 1,000 | $21.77 | $22k | 150,330 | SEC |
| Aug 12, 2026 | Aug 14, 2026 | UTI | Devincenzi Robert Thomas | Director | Bought | 1,000 | $25.95 | $26k | 149,330 | SEC |
| Aug 10, 2026 | Aug 12, 2026 | UTI | Devincenzi Robert Thomas | Director | Bought | 8,000 | $28.21 | $226k | 148,330 | SEC |
| Jun 29, 2026 | Jun 30, 2026 | UTI | Grant Jerome Alan | Chief Executive Officer | Sold | 94,500 | $41.40 | $3.9M | 335,715 | SEC |
| Jun 22, 2026 | Jun 24, 2026 | UTI | Prehn Kevin | Concorde Division President | Sold | 4,545 | $40.00 | $182k | 27,025 | SEC |
| Jun 8, 2026 | Jun 10, 2026 | UTI | Coliseum Capital Partners, L.P. | Director | Sold | 3M | $41.40 | $124M | 971,440 | SEC |
| Jun 5, 2026 | Jun 8, 2026 | UTI | Kline Christine | Senior Vice President and CAO | Sold | 3,500 | $44.42 | $155k | 43,006 | SEC |
| Jun 5, 2026 | Jun 8, 2026 | UTI | Lennox William J Jr | Director | Gift | 4,600 | 118,568 | SEC | ||
| May 27, 2026 | May 27, 2026 | UTI | Lorenz Tracy Kay | SVP and UTI Division President | Withheld for tax | 22,073 | $40.06 | $884k | 65,445 | SEC |
| May 25, 2026 | May 27, 2026 | UTI | Lorenz Tracy Kay | SVP and UTI Division President | Awarded | 42,243 | 87,518 | SEC | ||
| May 11, 2026 | May 13, 2026 | UTI | Srere Linda J | Director | Sold | 15,000 | $36.59 | $549k | 127,564 | SEC |
| Mar 27, 2026 | Mar 31, 2026 | UTI | Kevane Christopher E. | EVP and Chief Legal Officer | Sold | 23,654 | $37.55 | $888k | 83,521 | SEC |
| Mar 17, 2026 | Mar 18, 2026 | UTI | Brochick George W. | Director | Sold | 5,000 | $36.59 | $183k | 27,516 | SEC |
| Mar 6, 2026 | Mar 9, 2026 | UTI | Okinaka Shannon Lei | Director | Sold | 10,000 | $34.74 | $347k | 19,808 | SEC |
| Mar 5, 2026 | Mar 6, 2026 | UTI | Okinaka Shannon Lei | Director | Awarded | 3,565 | 29,808 | SEC | ||
| Mar 5, 2026 | Mar 6, 2026 | UTI | Slubowski Michael A. | Director | Awarded | 3,565 | 20,675 | SEC | ||
| Mar 5, 2026 | Mar 6, 2026 | UTI | Brochick George W. | Director | Awarded | 3,565 | 4,279 | SEC | ||
| Mar 5, 2026 | Mar 6, 2026 | UTI | Srere Linda J | Director | Awarded | 3,565 | 142,564 | SEC | ||
| Mar 5, 2026 | Mar 6, 2026 | UTI | Sanchez Loretta Lydia | Director | Awarded | 3,565 | 21,590 | SEC | ||
| Mar 5, 2026 | Mar 6, 2026 | UTI | Devincenzi Robert Thomas | Director | Awarded | 3,565 | 140,330 | SEC | ||
| Mar 5, 2026 | Mar 6, 2026 | UTI | Lennox William J Jr | Director | Awarded | 3,565 | 123,168 | SEC | ||
| Mar 5, 2026 | Mar 6, 2026 | UTI | Trammell Kenneth R | Director | Awarded | 3,565 | 136,083 | SEC | ||
| Mar 4, 2026 | Mar 6, 2026 | UTI | Hitchcock Todd A | EVP/COO | Sold | 16,500 | $37.33 | $616k | 104,084 | SEC |
| Mar 2, 2026 | Mar 4, 2026 | UTI | Smith Sherrell | EVP, Chief Academic Officer | Sold | 52,671 | $37.04 | $2M | 37,474 | SEC |
| Feb 27, 2026 | Mar 2, 2026 | UTI | Grant Jerome Alan | Chief Executive Officer | Sold | 60,040 | $34.95 | $2.1M | 430,215 | SEC |
| Feb 13, 2026 | Feb 17, 2026 | UTI | Frank Carolyn Ann | SVP/Chief HR Officer | Sold | 1,750 | $30.08 | $53k | 30,272 | SEC |
| Jan 21, 2026 | Jan 21, 2026 | UTI | Frank Carolyn Ann | SVP/Chief HR Officer | Withheld for tax | 2,162 | $27.49 | $59k | 32,022 | SEC |
| Dec 17, 2025 | Mar 4, 2026 | UTI | Smith Sherrell | EVP, Chief Academic Officer | Withheld for tax | 10,712 | $24.67 | $264k | 60,145 | SEC |
| Dec 17, 2025 | Dec 19, 2025 | UTI | Smith Sherrell | EVP, Chief Academic Officer | Withheld for tax | 1,321 | $26.06 | $34k | 159,375 | SEC |
| Dec 17, 2025 | Dec 19, 2025 | UTI | Prehn Kevin | Concorde Division President | Withheld for tax | 921 | $26.06 | $24k | 17,241 | SEC |
| Dec 17, 2025 | Dec 19, 2025 | UTI | Grant Jerome Alan | Chief Executive Officer | Withheld for tax | 9,276 | $26.06 | $242k | 490,255 | SEC |
| Dec 17, 2025 | Dec 19, 2025 | UTI | Frank Carolyn Ann | SVP/Chief HR Officer | Withheld for tax | 778 | $26.06 | $20k | 34,184 | SEC |
| Dec 17, 2025 | Dec 19, 2025 | UTI | Kline Christine | Senior Vice President and CAO | Withheld for tax | 2,171 | $26.06 | $57k | 46,506 | SEC |
| Dec 17, 2025 | Dec 19, 2025 | UTI | Hitchcock Todd A | EVP/COO | Withheld for tax | 2,454 | $26.06 | $64k | 120,584 | SEC |
| Dec 17, 2025 | Dec 19, 2025 | UTI | Schuman Bruce | Chief Financial Officer | Withheld for tax | 2,537 | $26.06 | $66k | 39,577 | SEC |
| Dec 17, 2025 | Dec 19, 2025 | UTI | DeTray Adrienne Dawn | SVP and CIO | Withheld for tax | 1,766 | $26.06 | $46k | 28,770 | SEC |
| Dec 17, 2025 | Dec 19, 2025 | UTI | Kevane Christopher E. | EVP and Chief Legal Officer | Withheld for tax | 1,670 | $26.06 | $44k | 107,175 | SEC |
| Dec 17, 2025 | Dec 19, 2025 | UTI | Lorenz Tracy Kay | UTI Division President | Withheld for tax | 880 | $26.06 | $23k | 45,275 | SEC |
| Dec 11, 2025 | Dec 12, 2025 | UTI | Hitchcock Todd A | EVP/COO | Withheld for tax | 14,949 | $24.55 | $367k | 123,038 | SEC |
| Dec 11, 2025 | Dec 12, 2025 | UTI | Smith Sherrell | EVP, Chief Academic Officer | Withheld for tax | 26,228 | $24.55 | $644k | 160,696 | SEC |
| Dec 11, 2025 | Dec 12, 2025 | UTI | Lorenz Tracy Kay | UTI Division President | Withheld for tax | 1,390 | $24.55 | $34k | 46,155 | SEC |
| Dec 11, 2025 | Dec 12, 2025 | UTI | Kevane Christopher E. | EVP and Chief Legal Officer | Withheld for tax | 16,722 | $24.55 | $411k | 108,845 | SEC |
| Dec 11, 2025 | Dec 12, 2025 | UTI | Prehn Kevin | Concorde Division President | Withheld for tax | 4,433 | $24.55 | $109k | 18,162 | SEC |
| Dec 11, 2025 | Dec 12, 2025 | UTI | Grant Jerome Alan | Chief Executive Officer | Withheld for tax | 111,720 | $24.55 | $2.7M | 499,531 | SEC |
| Dec 11, 2025 | Dec 12, 2025 | UTI | Grant Jerome Alan | Chief Executive Officer | Awarded | 72,233 | 611,251 | SEC | ||
| Dec 11, 2025 | Dec 12, 2025 | UTI | Kline Christine | Senior Vice President and CAO | Withheld for tax | 2,453 | $24.55 | $60k | 48,677 | SEC |
| Dec 10, 2025 | Mar 4, 2026 | UTI | Smith Sherrell | EVP, Chief Academic Officer | Awarded | 29,638 | 70,857 | SEC |
Sales, notices and lockups (179)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Jun 30, 2026 | Grant Jerome Alan | UTI | Chief Executive Officer | Form 4 sale | 94,500 | $3.9M | 22.0% | No plan | SEC |
| Jun 29, 2026 | Jun 29, 2026 | Grant Jerome Alan | UTI | Chief Executive Officer | Form 144 notice | 94,500 | $3.9M | Notice | SEC | |
| Jun 22, 2026 | Jun 24, 2026 | Prehn Kevin | UTI | Concorde Division President | Form 4 sale | 4,545 | $182k | 14.4% | No plan | SEC |
| Jun 22, 2026 | Jun 22, 2026 | Prehn Kevin | UTI | Concorde Division President | Form 144 notice | 4,545 | $182k | Notice | SEC | |
| Jun 8, 2026 | Jun 10, 2026 | Coliseum Capital Partners, L.P. | UTI | Director | Form 4 sale | 3M | $124M | 75.5% | Unusual | SEC |
| Jun 8, 2026 | Jun 8, 2026 | Coliseum Capital Management, LLC | UTI | Director | Form 144 notice | 4M | $173M | Notice | SEC | |
| Jun 5, 2026 | Jun 8, 2026 | Kline Christine | UTI | Senior Vice President and CAO | Form 4 sale | 3,500 | $155k | 7.5% | No plan | SEC |
| Jun 5, 2026 | Jun 5, 2026 | Kline Christine | UTI | Senior Vice President and CAO | Form 144 notice | 3,500 | $155k | Notice | SEC | |
| May 11, 2026 | May 13, 2026 | Srere Linda J | UTI | Director | Form 4 sale | 15,000 | $549k | 10.5% | No plan | SEC |
| May 11, 2026 | May 11, 2026 | Srere Linda J | UTI | Director | Form 144 notice | 15,000 | $536k | Notice | SEC | |
| Mar 27, 2026 | Mar 31, 2026 | Kevane Christopher E. | UTI | EVP and Chief Legal Officer | Form 4 sale | 23,654 | $888k | 22.1% | No plan | SEC |
| Mar 27, 2026 | Mar 27, 2026 | Kevane Christopher E. | UTI | EVP and Chief Legal Officer | Form 144 notice | 23,654 | $888k | Notice | SEC | |
| Mar 18, 2026 | Mar 18, 2026 | Brochick George W. | UTI | Director | Form 144 notice | 5,000 | $183k | Notice | SEC | |
| Mar 17, 2026 | Mar 18, 2026 | Brochick George W. | UTI | Director | Form 4 sale | 5,000 | $183k | 15.4% | No plan | SEC |
| Mar 6, 2026 | Mar 9, 2026 | Okinaka Shannon Lei | UTI | Director | Form 4 sale | 10,000 | $347k | 33.5% | Unusual | SEC |
| Mar 4, 2026 | Mar 6, 2026 | Hitchcock Todd A | UTI | EVP/COO | Form 4 sale | 16,500 | $616k | 13.7% | No plan | SEC |
| Mar 4, 2026 | Mar 4, 2026 | Okinaka Shannon Lei | UTI | Director | Form 144 notice | 10,000 | $375k | Notice | SEC | |
| Mar 4, 2026 | Mar 4, 2026 | Hitchcock Todd A | UTI | EVP/COO | Form 144 notice | 16,500 | $616k | Notice | SEC | |
| Mar 2, 2026 | Mar 4, 2026 | Smith Sherrell | UTI | EVP, Chief Academic Officer | Form 4 sale | 52,671 | $2M | 28.9% | Unusual | SEC |
| Mar 2, 2026 | Mar 2, 2026 | Smith Sherrell | UTI | EVP, Chief Academic Officer | Form 144 notice | 30,000 | $1.1M | Notice | SEC | |
| Mar 2, 2026 | Mar 2, 2026 | Smith Sherrell | UTI | EVP, Chief Academic Officer | Form 144 notice | 22,671 | $841k | Notice | SEC | |
| Feb 27, 2026 | Mar 2, 2026 | Grant Jerome Alan | UTI | Chief Executive Officer | Form 4 sale | 60,040 | $2.1M | 12.2% | No plan | SEC |
| Feb 27, 2026 | Feb 27, 2026 | Grant Jerome Alan | UTI | Chief Executive Officer | Form 144 notice | 60,040 | $2.1M | Notice | SEC | |
| Feb 13, 2026 | Feb 17, 2026 | Frank Carolyn Ann | UTI | SVP/Chief HR Officer | Form 4 sale | 1,750 | $53k | 5.5% | No plan | SEC |
| Feb 13, 2026 | Feb 13, 2026 | Frank Carolyn Ann | UTI | SVP/Chief HR Officer | Form 144 notice | 1,750 | $53k | Notice | SEC | |
| May 27, 2025 | May 29, 2025 | Shackelton Christopher S | UTI | Director | Form 4 sale | 500,000 | $17.5M | 15.5% | No plan | SEC |
| May 15, 2025 | May 16, 2025 | Hitchcock Todd A | UTI | EVP/COO | Form 4 sale | 27,500 | $917k | 25.5% | Unusual | SEC |
| May 15, 2025 | May 15, 2025 | Hitchcock Todd A | UTI | EVP/COO | Form 144 notice | 27,500 | $917k | Notice | SEC | |
| May 13, 2025 | May 15, 2025 | Brochick George W. | UTI | Director | Form 4 sale | 6,000 | $191k | 15.6% | No plan | SEC |
| May 12, 2025 | Mar 6, 2026 | Smith Sherrell | UTI | EVP, Chief Academic Officer | Form 4 sale | 50,000 | $1.7M | 54.8% | Unusual | SEC |
| May 12, 2025 | May 14, 2025 | Kevane Christopher E. | UTI | EVP and Chief Legal Officer | Form 4 sale | 29,400 | $1M | 28.5% | Unusual | SEC |
| May 12, 2025 | May 14, 2025 | Grant Jerome Alan | UTI | Chief Executive Officer | Form 4 sale | 56,492 | $1.9M | 14.1% | No plan | SEC |
| May 12, 2025 | May 14, 2025 | Coliseum Capital, LLC | UTI | Director | Form 4 sale | 1.9M | $63.6M | 37.5% | Unusual | SEC |
| May 12, 2025 | May 12, 2025 | Smith Lori B | UTI | SVP Chief Information Officer | Form 144 notice | 50,000 | $1.7M | Notice | SEC | |
| May 12, 2025 | May 12, 2025 | Grant Jerome Alan | UTI | Chief Executive Officer | Form 144 notice | 56,492 | $1.9M | Notice | SEC | |
| May 12, 2025 | May 12, 2025 | Kevane Christopher E. | UTI | EVP and Chief Legal Officer | Form 144 notice | 29,400 | $1M | Notice | SEC | |
| Apr 15, 2025 | Apr 17, 2025 | Smith Sherrell | UTI | EVP, Chief Academic Officer | Form 4 sale | 97 | $3k | 0.1% | Routine | SEC |
| Apr 15, 2025 | Apr 15, 2025 | Smith Sherrell | UTI | EVP, Chief Academic Officer | Form 144 notice | 97 | $3k | Notice | SEC | |
| Apr 9, 2025 | Apr 11, 2025 | Smith Sherrell | UTI | EVP, Chief Academic Officer | Form 4 sale | 208 | $6k | 0.2% | Routine | SEC |
| Apr 9, 2025 | Apr 9, 2025 | Smith Sherrell | UTI | EVP, Chief Academic Officer | Form 144 notice | 208 | $6k | Notice | SEC | |
| Mar 27, 2025 | Mar 28, 2025 | Coliseum Capital, LLC | UTI | Director, 10% owner | Form 4 sale | 1M | $25.4M | 16.3% | No plan | SEC |
| Mar 27, 2025 | Mar 27, 2025 | Coliseum Capital Management, LLC | UTI | Director | Form 144 notice | 4.1M | $110M | Notice | SEC | |
| Mar 21, 2025 | Mar 25, 2025 | Smith Sherrell | UTI | EVP, Chief Academic Officer | Form 4 sale | 10,000 | $270k | 6.0% | Routine | SEC |
| Mar 21, 2025 | Mar 21, 2025 | Smith Sherrell | UTI | EVP, Chief Academic Officer | Form 144 notice | 10,000 | $269k | Notice | SEC | |
| Mar 20, 2025 | Mar 21, 2025 | Smith Sherrell | UTI | EVP, Chief Academic Officer | Form 4 sale | 49,695 | $1.4M | 22.9% | Routine | SEC |
| Mar 20, 2025 | Mar 20, 2025 | Smith Sherrell | UTI | EVP, Chief Academic Officer | Form 144 notice | 10,249 | $286k | Notice | SEC | |
| Mar 19, 2025 | Mar 19, 2025 | Smith Sherrell | UTI | EVP, Chief Academic Officer | Form 144 notice | 39,446 | $1.1M | Notice | SEC | |
| Mar 18, 2025 | Mar 19, 2025 | Smith Sherrell | UTI | EVP, Chief Academic Officer | Form 4 sale | 46,773 | $1.2M | 17.7% | Routine | SEC |
| Mar 18, 2025 | Mar 18, 2025 | Smith Sherrell | UTI | EVP, Chief Academic Officer | Form 144 notice | 10,000 | $267k | Notice | SEC | |
| Mar 17, 2025 | Mar 17, 2025 | Smith Sherrell | UTI | EVP, Chief Academic Officer | Form 144 notice | 60,000 | $1.6M | Notice | SEC |